Conceptio › Archive › bioRxiv / medRxiv
bioRxiv / medRxivopen access

Real-world activity of trastuzumab deruxtecan in heavily pretreated HER2-expressing ovarian cancer: focusing on HER2-low responses and CCNE1 amplification

Voelker, G. D. et al. · 2026
bioRxiv / medRxiv · Papers · License: Open Access · 2026
Open Source ↗
oncology
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 410918
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.